Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Paweł Grychnik has a total of 54 co-authors. Here are the top co-authors by number of shared publications:

  • Angelika Tkaczyk-Wlizło

    Institute of Biological Bases of Animal Production, Faculty of Animal Sciences and Bioeconomy, University of Life Sciences in Lublin, 20-950 Lublin, Poland

    3 shared publications
  • Brygida Ślaska

    Institute of Biological Bases of Animal Production, Faculty of Animal Sciences and Bioeconomy, University of Life Sciences in Lublin, 20-950 Lublin, Poland

    3 shared publications
  • Kaja Ziółkowska-Twarowska

    Institute of Biological Bases of Animal Production, Faculty of Animal Sciences and Bioeconomy, University of Life Sciences in Lublin, 20-950 Lublin, Poland

    3 shared publications
  • Krzysztof Kowal

    Institute of Biological Bases of Animal Production, Faculty of Animal Sciences and Bioeconomy, University of Life Sciences in Lublin, 20-950 Lublin, Poland

    3 shared publications
  • Adam Lepczyński

    Department of Animal Anatomy and Physiology, Faculty of Biotechnology and Animal Sciences, West Pomeranian University of Technology in Szczecin, 70-310 Szczecin, Poland

    2 shared publications
  • Agnieszka Herosimczyk

    Department of Physiology, Cytobiology and Proteomics, Faculty of Biotechnology and Animal Husbandry, West Pomeranian University of Technology Szczecin, Klemensa Janickiego 29, 71-270 Szczecin, Poland

    2 shared publications

Latest Publications

  • Open Access

    Complete Mitochondrial Genome of a French Bulldog with Carcinoma planoepitheliale keratodes G1: A Descriptive Case Report

    by Krzysztof Kowal, Kaja Ziółkowska-Twarowska, Bartłomiej Kiecak, Norbert Ozga, Angelika Tkaczyk-Wlizło, Paweł Grychnik, Ludmiła Grzybowska-Szatkowska, Brygida Ślaska

    French Bulldogs, like other brachycephalic breeds, are predisposed to a variety of genetic and tumour-related disorders. While mitochondrial DNA (mtDNA) mutations have been documented in canine tumours, no prior study has examined the entire mitochondrial genome in this breed. In this study, we analysed mtDNA obtained from blood and tumour tissue of a 10-year-old male French Bulldog diagnosed with carcinoma planoepitheliale keratodes (G1). Complete sequencing and comparative bioinformatic analysis revealed 22 sequence variants, including nine in protein-coding genes, two in RNA-coding genes, two in the control region, and nine within the variable number tandem repeat (VNTR) region. Identical variants were present in both blood and tumour tissue, indicating that no detectable tumour-specific mtDNA mutations were observed. Notably, the m.1397A>T transversion in the 16S rRNA gene and an insertion (m.2679_2680insG) in the tRNA-Leu(UUR) gene were identified, both mapping to conserved loci in the human mitochondrial genome. Among the coding variants, four nonsynonymous variants (including p.Cys55Tyr and p.Ser471Asn) were detected, two of which affected highly conserved amino acid positions. Most nonsynonymous changes were localised in random coil regions and internal mitochondrial compartments, whereas synonymous changes appeared mainly within transmembrane helices. The control region displayed the highest degree of polymorphism, including eight positions with A/G heteroplasmy and one length variant due to polyT extension. These findings represent the first documentation of full mitochondrial genome sequence variants in a French Bulldog with cancer providing descriptive data for future breed population and oncological research. Further studies are warranted to determine whether these alterations are breed- or tumour-specific.

  • Open Access

    Hepatoprotective Potential of Curcumin in the Prevention of Liver Dysfunction in a Porcine Model

    by Kamila Kibitlewska, Varunkumar Asediya, Krzysztof Karpiesiuk, Urszula Czarnik, Marek Lecewicz, Paweł Wysocki, Prarthana Sharma, Iwona Otrocka-Domagała, Łukasz Zielonka, Andrzej Pomianowski, et al.

    Curcumin, the major polyphenolic constituent of Curcuma longa, has been widely investigated as a hepatoprotective adjunct due to its antioxidant and immunomodulatory properties. This review evaluates the relevance of curcumin for the prevention and management of liver dysfunction and hepatitis in pigs by synthesizing available porcine evidence and integrating mechanistic insights from translational liver injury models where pig-specific data remain limited. Across experimental hepatic injury contexts, curcumin administration is most consistently associated with reduced biochemical and structural indicators of hepatocellular damage, including decreased aminotransferase activity, attenuation of lipid peroxidation, and enhancement of endogenous antioxidant defenses. These effects are mechanistically linked to suppression of pro-inflammatory signaling pathways, particularly NF-κB-related transcriptional activity and inflammasome-associated responses, together with reduced expression of key cytokines such as TNF-α, IL-1β, and IL-6. Concurrent activation of Nrf2-centered cytoprotective pathways and induction of phase II antioxidant enzymes (including HO-1, GST, and NQO1) appear to constitute a conserved axis supporting hepatic oxidative stress resilience. In swine-relevant infectious settings, available data further support antiviral activity against selected porcine pathogens, including classical swine fever virus and porcine reproductive and respiratory syndrome virus, potentially mediated through interference with lipid-dependent stages of viral replication and modulation of Kupffer cell activation. Although combination strategies with established hepatoprotective approaches are conceptually attractive, current synergy evidence remains heterogeneous and largely extrapolated. Overall, curcumin represents a plausible adjunct candidate for supporting porcine liver health; however, translation into practice will depend on resolving formulation-dependent bioavailability constraints and strengthening the pig-specific evidence base.


  • Open Access

    Hepatoprotective Effect of Silymarin Herb in Prevention of Liver Dysfunction Using Pig as Animal Model

    by Prarthana Sharma, Varun Asediya, Garima Kalra, Sharmin Sultana, Nihal Purohit, Kamila Kibitlewska, Wojciech Kozera, Urszula Czarnik, Krzysztof Karpiesiuk, Marek Lecewicz, et al.

    Silymarin, a flavonolignan-rich extract of Silybum marianum, is widely recognized for its hepatoprotective potential. While rodent studies predominate, pigs (Sus scrofa) offer a more translationally relevant model due to their hepatic architecture, bile acid composition, and transporter expression, which closely resemble those of humans. This narrative review synthesises current evidence on the chemistry, pharmacokinetics, biodistribution, and hepatoprotective activity of silymarin in porcine models. Available studies demonstrate that when adequate intrahepatic exposure is achieved, particularly through optimised formulations, silymarin can attenuate oxidative stress, suppress inflammatory signalling, stabilise mitochondria, and modulate fibrogenic pathways. Protective effects have been reported across diverse porcine injury paradigms, including toxin-induced necrosis, ethanol- and diet-associated steatosis, metabolic dysfunction, ischemia–reperfusion injury, and partial hepatectomy. However, the evidence base remains limited, with few long-term studies addressing fibrosis or regeneration, and methodological heterogeneity complicates the comparison of data across studies. Current knowledge gaps in silymarin research include inconsistent chemotype characterization among plant sources, limited reporting of unbound pharmacokinetic parameters, and variability in histological scoring criteria across studies, which collectively hinder cross-study comparability and mechanistic interpretation. Advances in analytical chemistry, transporter biology, and formulation design are beginning to refine the interpretation of exposure–response relationships. Advances in analytical chemistry, transporter biology, and formulation design are beginning to refine the interpretation of exposure–response relationships. In parallel, emerging computational approaches, including machine-learning-assisted chemotype fingerprinting, automated histology scoring, and Bayesian exposure modeling, are being explored as supportive tools to enhance reproducibility and translational relevance; however, these frameworks remain exploratory and require empirical validation, particularly in modeling enterohepatic recirculation. Collectively, current porcine evidence supports silymarin as a context-dependent yet credible hepatoprotective agent, highlighting priorities for future research to better define its therapeutic potential in clinical nutrition and veterinary practice.


  • The impact of aflatoxin B1 on pig (Sus scrofa) and human (Homo sapiens)

    by Paweł Grychnik, Kaja Ziółkowska, Krzysztof Kowal, Angelika Tkaczyk-Wlizło, Athul P. Kurian, Sharmin Sultana, Garima Kalra, Nihal Purohit, Chandra S. Pareek, Brygida Ślaska

  • Comparison of column-based and organic GTPC methods of RNA isolation from pig liver

    by Paweł Grychnik, Kaja Ziołkowska, Angelika Tkaczyk-Wlizło, Krzysztof Kowal, Brygida Ślaska